查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1842394

全球荷尔蒙补充疗法市场：市场规模、份额和趋势分析（按产品、给药途径、疾病类型和地区划分），细分市场预测（2025-2033 年）

Hormone Replacement Therapy Market Size, Share & Trends Analysis Report By Product, (HGH Replacement Therapy), By Route of Administration, By Disease Type, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

荷尔蒙补充疗法市场摘要

全球荷尔蒙补充疗法市场预计在 2024 年达到 235.8 亿美元，预计到 2033 年将达到 394.2 亿美元，2025 年至 2033 年的复合年增长率为 5.8%。

由于激素紊乱症的盛行率不断上升，尤其是在老年族群中，荷尔蒙补充疗法产业正在蓬勃发展。

与更年期相关的症状，例如潮热、盗汗、阴道干涩和骨质疏鬆，推动了对有效治疗方法的需求。例如，2024年10月，StatPearls Publishing报告了一项名为「停经后雌激素/黄体素干预试验」的研究，该研究纳入了875名使用荷尔蒙替代疗法（HRT）来控制中度至重度血管舒缩症状的女性。研究发现，与安慰剂组相比，仅使用雌激素组（OR=0.42；95% CI：0.28-0.62）和雌激素加黄体素组（OR=0.38；95% CI：0.25-0.58）的症状均显着减轻。虽然这项研究强调了HRT在缓解症状方面的重要性，但也揭示了其在预防慢性疾病方面作用有限。男性性腺功能低下症症的日益普及以及预期寿命的延长，进一步推动了市场对HRT的接受度。

牛津皇家全科医师学会研究与监测中心的一项研究分析了来自465家全科诊所的180万份医疗记录，结果显示，在接受雌激素类激素替代疗法（HRT）的5451名女性中，新冠病毒感染率和死亡率降低了78%。人们对更年期、性腺功能减退和生长激素缺乏等疾病的认识不断提高，使得患者群体日益扩大。製药公司正在推出创新治疗方法以满足市场需求。例如，2022年1月，Ascendis Pharma A/S公司的SKYTROFA获得了欧盟委员会的核准，这是第一个用于治疗儿童生长激素缺乏症的每週一次的疗法，与每日註射相比，该疗法具有更高的依从性和便利性。

市场成长进一步受到人们对荷尔蒙缺乏症和罕见疾病认识提高的推动。总部位于英国的儿童生长基金会等机构为患者、看护者和医疗保健提供者提供教育、指导和支持，从而促进荷尔蒙替代疗法（HRT）的普及。儘管发展势头强劲，但高昂的治疗费用在某些地区仍然是一大障碍。注射型HRT的年费用，用户为288美元至1440美元，无保险用户为480美元至4800美元，限制了其可及性。然而，患者意识的提高、创新的药物传递方法以及治疗应用的不断拓展，预计将持续推动荷尔蒙补充疗法产业的长期成长。

目录

第一章 分析方法和范围

第二章执行摘要

第三章荷尔蒙补充疗法市场：影响因素、趋势和范围

  • 市场联动展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 商业环境分析
    • 产业分析：波特五力分析
    • PESTEL 分析
    • 管道分析
    • 专利到期分析
    • 定价分析

第四章荷尔蒙补充疗法市场：按产品分類的业务分析

  • 按产品分類的市场份额（2024 年和 2033 年）
  • 产品仪錶板
  • 按产品分類的市场规模预测和趋势分析（2021-2033）
  • 雌激素-黄体素替代疗法
  • 生长激素替代疗法
  • 甲状腺荷尔蒙补充疗法
  • 睾酮替代疗法
  • 副甲状腺素替代疗法

第五章荷尔蒙补充疗法市场：按给药途径分類的业务分析

  • 按给药途径分類的市场份额（2024 年和 2033 年）
  • 管理路线仪錶板
  • 按给药途径分類的市场规模预测和趋势分析（2021-2033）
  • 口服
  • 肠外
  • 经皮
  • 其他的

第六章荷尔蒙补充疗法市场：依疾病类型分類的商业分析

  • 按疾病类型分類的市场份额（2024 年和 2033 年）
  • 疾病类型仪錶板
  • 按疾病类型分類的市场规模预测和趋势分析（2021-2033 年）
  • 闭经
  • 甲状腺机能低下症
  • 男性性腺功能低下症
  • 生长激素缺乏症
  • 甲状旁腺功能低下症

第七章荷尔蒙补充疗法市场：区域估算与趋势分析

  • 按地区分類的市场份额分析（2024 年和 2033 年）
  • 市场概览：按地区
  • 市场规模预测及趋势分析（2021-2033）
  • 北美洲
    • 按国家/地区划分（2021-2033 年）
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争情势

  • 参与企业概况
  • 企业市场分析
  • 公司分类
  • 策略规划
  • 公司简介/上市公司
    • Eli Lilly and Company
    • Bayer AG
    • Noven Pharmaceuticals, Inc.
    • Pfizer Inc.
    • Merck &Co., Inc.
    • Viatris, Inc.
    • Novo Nordisk A/S
    • F. Hoffmann-La Roche Ltd.
    • ASCEND Therapeutics US, LLC.
    • AbbVie, Inc.
Product Code: 978-1-68038-784-1

Hormone Replacement Therapy Market Summary

The global hormone replacement therapy market size was estimated at USD 23.58 billion in 2024 and is projected to reach USD 39.42 billion by 2033, growing at a CAGR of 5.8% from 2025 to 2033. The hormone replacement therapy industry is gaining momentum due to the rising prevalence of hormonal disorders, especially among aging populations.

Menopause-related conditions such as hot flashes, night sweats, vaginal dryness, and osteoporosis are fueling demand for effective therapies. For instance, October 2024, StatPearls Publishing reported that HRT was used to manage moderate-to-severe vasomotor symptoms, with the Postmenopausal Estrogen/Progestin Interventions trial of 875 women showing significant symptom reduction in estrogen-alone (OR, 0.42; 95% CI, 0.28-0.62) and estrogen-plus-progestin groups (OR, 0.38; 95% CI, 0.25-0.58) compared to placebo. The study clarified HRT's limited role in chronic disease prevention while highlighting its importance in symptom relief. Growing awareness of male hypogonadism, coupled with rising life expectancy, further expands market adoption.

A study by the Oxford-Royal College of General Practitioners Research and Surveillance Centre, analyzing 1.8 million medical records from 465 general practices, reported that 5,451 women on estrogen-based HRT experienced a 78% reduction in COVID-19 infection and mortality rates. Rising awareness of conditions such as menopause, hypogonadism, and growth hormone deficiency is expanding the patient base. Pharmaceutical companies are introducing innovative therapies to meet demand. For example, in January 2022, Ascendis Pharma A/S received European Commission approval for SKYTROFA, the first once-weekly treatment for pediatric growth hormone deficiency, offering improved adherence and convenience compared to daily injections.

Market growth is further supported by increasing awareness of hormone deficiencies and rare disorders. Organizations like the UK-based Child Growth Foundation provide education, guidance, and support to patients, caregivers, and healthcare providers, enhancing adoption of HRT. Despite this momentum, high treatment costs remain a barrier in certain regions. Annual injectable HRT costs range from USD 288 to USD 1,440 for insured patients and USD 480 to USD 4,800 for uninsured individuals, limiting accessibility. Nevertheless, rising patient awareness, innovative drug delivery methods, and expanded therapeutic applications are expected to sustain long-term growth in the hormone replacement therapy industry.

Global Hormone Replacement Therapy Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global hormone replacement therapy market report based on product, route of administration, disease type, and region:

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Estrogen & Progesterone Replacement Therapy
  • HGH Replacement Therapy
  • Thyroid Hormone Replacement Therapy
  • Testosterone Replacement Therapy
  • Parathyroid Hormone Replacement
  • Route of Administration Outlook (Revenue, USD Million, 2021 - 2033)
  • Oral
  • Parenteral
  • Transdermal
  • Others
  • Disease Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Menopause
  • Hypothyroidism
  • Male Hypogonadism
  • Growth Hormone Deficiency
  • Hypoparathyroidism
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Route of Administration
    • 1.2.3. Disease Type
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Hormone Replacement Therapy Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis
    • 3.3.3. Pipeline Analysis
    • 3.3.4. Patent Expiry Analysis
    • 3.3.5. Pricing Analysis

Chapter 4. Hormone Replacement Therapy Market: Product Business Analysis

  • 4.1. Product Market Share, 2024 & 2033
  • 4.2. Product Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Product, 2021 to 2033 (USD Million)
  • 4.4. Estrogen & Progesterone Replacement Therapy
    • 4.4.1. Estrogen & Progesterone Replacement Therapy Market, 2021 - 2033 (USD Million)
  • 4.5. HGH Replacement Therapy
    • 4.5.1. HGH Replacement Therapy Market, 2021 - 2033 (USD Million)
  • 4.6. Thyroid Hormone Replacement Therapy
    • 4.6.1. Thyroid Hormone Replacement Therapy Market, 2021 - 2033 (USD Million)
  • 4.7. Testosterone Replacement Therapy
    • 4.7.1. Testosterone Replacement Therapy Market, 2021 - 2033 (USD Million)
  • 4.8. Parathyroid Hormone Replacement
    • 4.8.1. Parathyroid Hormone Replacement Market, 2021 - 2033 (USD Million)

Chapter 5. Hormone Replacement Therapy Market: Route of Administration Business Analysis

  • 5.1. Route of Administration Market Share, 2024 & 2033
  • 5.2. Route of Administration Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Route of administration, 2021 to 2033 (USD Million)
  • 5.4. Oral
    • 5.4.1. Oral Market, 2021 - 2033 (USD Million)
  • 5.5. Parenteral
    • 5.5.1. Parenteral Market, 2021 - 2033 (USD Million)
  • 5.6. Transdermal
    • 5.6.1. Transdermal Market, 2021 - 2033 (USD Million)
  • 5.7. Others
    • 5.7.1. Others Market, 2021 - 2033 (USD Million)

Chapter 6. Hormone Replacement Therapy Market: Disease Type Business Analysis

  • 6.1. Disease Type Market Share, 2024 & 2033
  • 6.2. Disease Type Segment Dashboard
  • 6.3. Market Size & Forecasts and Trend Analysis, by Disease type, 2021 to 2033 (USD Million)
  • 6.4. Menopause
    • 6.4.1. Menopause Market, 2021 - 2033 (USD Million)
  • 6.5. Hypothyroidism
    • 6.5.1. Hypothyroidism Market, 2021 - 2033 (USD Million)
  • 6.6. Male Hypogonadism
    • 6.6.1. Male Hypogonadism Market, 2021 - 2033 (USD Million)
  • 6.7. Growth Hormone Deficiency
    • 6.7.1. Growth Hormone Deficiency Market, 2021 - 2033 (USD Million)
  • 6.8. Hypoparathyroidism
    • 6.8.1. Hypoparathyroidism Market, 2021 - 2033 (USD Million)

Chapter 7. Hormone Replacement Therapy Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2024 & 2033
  • 7.2. Regional Market Dashboard
  • 7.3. Market Size & Forecasts Trend Analysis, 2021 to 2033:
  • 7.4. North America
    • 7.4.1. North America Hormone Replacement Therapy Market Estimates and Forecasts, By Country, 2021 - 2033 (USD Million)
    • 7.4.2. U.S.
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Target Disease Prevalence
      • 7.4.2.3. Regulatory Framework
      • 7.4.2.4. Reimbursement Framework
      • 7.4.2.5. U.S. Hormone Replacement Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.3. Canada
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Target Disease Prevalence
      • 7.4.3.3. Regulatory Framework
      • 7.4.3.4. Reimbursement Framework
      • 7.4.3.5. Canada Hormone Replacement Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.4. Mexico
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Target Disease Prevalence
      • 7.4.4.3. Regulatory Framework
      • 7.4.4.4. Reimbursement Framework
      • 7.4.4.5. Mexico Hormone Replacement Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5. Europe
    • 7.5.1. Europe Hormone Replacement Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.2. UK
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Target Disease Prevalence
      • 7.5.2.3. Regulatory Framework
      • 7.5.2.4. Reimbursement Framework
      • 7.5.2.5. UK Hormone Replacement Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.3. Germany
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Target Disease Prevalence
      • 7.5.3.3. Regulatory Framework
      • 7.5.3.4. Reimbursement Framework
      • 7.5.3.5. Germany Hormone Replacement Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.4. France
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Target Disease Prevalence
      • 7.5.4.3. Regulatory Framework
      • 7.5.4.4. Reimbursement Framework
      • 7.5.4.5. France Hormone Replacement Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.5. Italy
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Target Disease Prevalence
      • 7.5.5.3. Regulatory Framework
      • 7.5.5.4. Reimbursement Framework
      • 7.5.5.5. Italy Hormone Replacement Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.6. Spain
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Target Disease Prevalence
      • 7.5.6.3. Regulatory Framework
      • 7.5.6.4. Reimbursement Framework
      • 7.5.6.5. Spain Hormone Replacement Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.7. Denmark
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Target Disease Prevalence
      • 7.5.7.3. Regulatory Framework
      • 7.5.7.4. Reimbursement Framework
      • 7.5.7.5. Denmark Hormone Replacement Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.8. Sweden
      • 7.5.8.1. Key Country Dynamics
      • 7.5.8.2. Target Disease Prevalence
      • 7.5.8.3. Regulatory Framework
      • 7.5.8.4. Reimbursement Framework
      • 7.5.8.5. Sweden Hormone Replacement Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.9. Norway
      • 7.5.9.1. Key Country Dynamics
      • 7.5.9.2. Target Disease Prevalence
      • 7.5.9.3. Regulatory Framework
      • 7.5.9.4. Reimbursement Framework
      • 7.5.9.5. Norway Hormone Replacement Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Asia Pacific Hormone Replacement Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.2. Japan
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Target Disease Prevalence
      • 7.6.2.3. Regulatory Framework
      • 7.6.2.4. Reimbursement Framework
      • 7.6.2.5. Japan Hormone Replacement Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.3. China
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Target Disease Prevalence
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. Reimbursement Framework
      • 7.6.3.5. China Hormone Replacement Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.4. India
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Target Disease Prevalence
      • 7.6.4.3. Regulatory Framework
      • 7.6.4.4. Reimbursement Framework
      • 7.6.4.5. India Hormone Replacement Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.5. Australia
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Target Disease Prevalence
      • 7.6.5.3. Regulatory Framework
      • 7.6.5.4. Reimbursement Framework
      • 7.6.5.5. Australia Hormone Replacement Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.6. South Korea
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Target Disease Prevalence
      • 7.6.6.3. Regulatory Framework
      • 7.6.6.4. Reimbursement Framework
      • 7.6.6.5. South Korea Hormone Replacement Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.7. Thailand
      • 7.6.7.1. Key Country Dynamics
      • 7.6.7.2. Target Disease Prevalence
      • 7.6.7.3. Regulatory Framework
      • 7.6.7.4. Reimbursement Framework
      • 7.6.7.5. Thailand Hormone Replacement Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Latin America Hormone Replacement Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Target Disease Prevalence
      • 7.7.2.3. Regulatory Framework
      • 7.7.2.4. Reimbursement Framework
      • 7.7.2.5. Brazil Hormone Replacement Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.3. Argentina
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Target Disease Prevalence
      • 7.7.3.3. Regulatory Framework
      • 7.7.3.4. Reimbursement Framework
      • 7.7.3.5. Argentina Hormone Replacement Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.8. Middle East and Africa
    • 7.8.1. Middle East and Africa Hormone Replacement Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.8.2. South Africa
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Target Disease Prevalence
      • 7.8.2.3. Regulatory Framework
      • 7.8.2.4. Reimbursement Framework
      • 7.8.2.5. South Africa Hormone Replacement Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Target Disease Prevalence
      • 7.8.3.3. Regulatory Framework
      • 7.8.3.4. Reimbursement Framework
      • 7.8.3.5. Saudi Arabia Hormone Replacement Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.8.4. UAE
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Target Disease Prevalence
      • 7.8.4.3. Regulatory Framework
      • 7.8.4.4. Reimbursement Framework
      • 7.8.4.5. UAE Hormone Replacement Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.8.5. Kuwait
      • 7.8.5.1. Key Country Dynamics
      • 7.8.5.2. Target Disease Prevalence
      • 7.8.5.3. Regulatory Framework
      • 7.8.5.4. Reimbursement Framework
      • 7.8.5.5. Kuwait Hormone Replacement Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Participant Overview
  • 8.2. Company Market Position Analysis
  • 8.3. Company Categorization
  • 8.4. Strategy Mapping
  • 8.5. Company Profiles/Listing
    • 8.5.1. Eli Lilly and Company
      • 8.5.1.1. Overview
      • 8.5.1.2. Financial Performance
      • 8.5.1.3. Product Benchmarking
      • 8.5.1.4. Strategic Initiatives
    • 8.5.2. Bayer AG
      • 8.5.2.1. Overview
      • 8.5.2.2. Financial Performance
      • 8.5.2.3. Product Benchmarking
      • 8.5.2.4. Strategic Initiatives
    • 8.5.3. Noven Pharmaceuticals, Inc.
      • 8.5.3.1. Overview
      • 8.5.3.2. Financial Performance
      • 8.5.3.3. Product Benchmarking
      • 8.5.3.4. Strategic Initiatives
    • 8.5.4. Pfizer Inc.
      • 8.5.4.1. Overview
      • 8.5.4.2. Financial Performance
      • 8.5.4.3. Product Benchmarking
      • 8.5.4.4. Strategic Initiatives
    • 8.5.5. Merck & Co., Inc.
      • 8.5.5.1. Overview
      • 8.5.5.2. Financial Performance
      • 8.5.5.3. Product Benchmarking
      • 8.5.5.4. Strategic Initiatives
    • 8.5.6. Viatris, Inc.
      • 8.5.6.1. Overview
      • 8.5.6.2. Financial Performance
      • 8.5.6.3. Product Benchmarking
      • 8.5.6.4. Strategic Initiatives
    • 8.5.7. Novo Nordisk A/S
      • 8.5.7.1. Overview
      • 8.5.7.2. Financial Performance
      • 8.5.7.3. Product Benchmarking
      • 8.5.7.4. Strategic Initiatives
    • 8.5.8. F. Hoffmann-La Roche Ltd.
      • 8.5.8.1. Overview
      • 8.5.8.2. Financial Performance
      • 8.5.8.3. Product Benchmarking
      • 8.5.8.4. Strategic Initiatives
    • 8.5.9. ASCEND Therapeutics US, LLC.
      • 8.5.9.1. Overview
      • 8.5.9.2. Financial Performance
      • 8.5.9.3. Product Benchmarking
      • 8.5.9.4. Strategic Initiatives
    • 8.5.10. AbbVie, Inc.
      • 8.5.10.1. Overview
      • 8.5.10.2. Financial Performance
      • 8.5.10.3. Product Benchmarking
      • 8.5.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global hormone replacement therapy market, by region, 2021 - 2033 (USD Million)
  • Table 4 Global hormone replacement therapy market, by product, 2021 - 2033 (USD Million)
  • Table 5 Global hormone replacement therapy market, by route of administration, 2021 - 2033 (USD Million)
  • Table 6 Global hormone replacement therapy market, by disease type, 2021 - 2033 (USD Million)
  • Table 7 North America hormone replacement therapy market, by country, 2021 - 2033 (USD Million)
  • Table 8 North America hormone replacement therapy market, by product, 2021 - 2033 (USD Million)
  • Table 9 North America hormone replacement therapy market, by route of administration, 2021 - 2033 (USD Million)
  • Table 10 North America hormone replacement therapy market, by disease type, 2021 - 2033 (USD Million)
  • Table 11 U.S. hormone replacement therapy market, by product, 2021 - 2033 (USD Million)
  • Table 12 U.S. hormone replacement therapy market, by route of administration, 2021 - 2033 (USD Million)
  • Table 13 U.S. hormone replacement therapy market, by disease type, 2021 - 2033 (USD Million)
  • Table 14 Canada hormone replacement therapy market, by product, 2021 - 2033 (USD Million)
  • Table 15 Canada hormone replacement therapy market, by route of administration, 2021 - 2033 (USD Million)
  • Table 16 Canada hormone replacement therapy market, by disease type, 2021 - 2033 (USD Million)
  • Table 17 Mexico hormone replacement therapy market, by product, 2021 - 2033 (USD Million)
  • Table 18 Mexico hormone replacement therapy market, by route of administration, 2021 - 2033 (USD Million)
  • Table 19 Mexico hormone replacement therapy market, by disease type, 2021 - 2033 (USD Million)
  • Table 20 Europe hormone replacement therapy market, by country, 2021 - 2033 (USD Million)
  • Table 21 Europe hormone replacement therapy market, by product, 2021 - 2033 (USD Million)
  • Table 22 Europe hormone replacement therapy market, by route of administration, 2021 - 2033 (USD Million)
  • Table 23 Europe hormone replacement therapy market, by disease type, 2021 - 2033 (USD Million)
  • Table 24 UK hormone replacement therapy market, by product, 2021 - 2033 (USD Million)
  • Table 25 UK hormone replacement therapy market, by route of administration, 2021 - 2033 (USD Million)
  • Table 26 UK hormone replacement therapy market, by disease type, 2021 - 2033 (USD Million)
  • Table 27 Germany hormone replacement therapy market, by product, 2021 - 2033 (USD Million)
  • Table 28 Germany hormone replacement therapy market, by route of administration, 2021 - 2033 (USD Million)
  • Table 29 Germany hormone replacement therapy market, by disease type, 2021 - 2033 (USD Million)
  • Table 30 France hormone replacement therapy market, by product, 2021 - 2033 (USD Million)
  • Table 31 France hormone replacement therapy market, by route of administration, 2021 - 2033 (USD Million)
  • Table 32 France hormone replacement therapy market, by disease type, 2021 - 2033 (USD Million)
  • Table 33 Italy hormone replacement therapy market, by product, 2021 - 2033 (USD Million)
  • Table 34 Italy hormone replacement therapy market, by route of administration, 2021 - 2033 (USD Million)
  • Table 35 Italy hormone replacement therapy market, by disease type, 2021 - 2033 (USD Million)
  • Table 36 Spain hormone replacement therapy market, by product, 2021 - 2033 (USD Million)
  • Table 37 Spain hormone replacement therapy market, by route of administration, 2021 - 2033 (USD Million)
  • Table 38 Spain hormone replacement therapy market, by disease type, 2021 - 2033 (USD Million)
  • Table 39 Norway hormone replacement therapy market, by product, 2021 - 2033 (USD Million)
  • Table 40 Norway hormone replacement therapy market, by route of administration, 2021 - 2033 (USD Million)
  • Table 41 Norway hormone replacement therapy market, by disease type, 2021 - 2033 (USD Million)
  • Table 42 Denmark hormone replacement therapy market, by product, 2021 - 2033 (USD Million)
  • Table 43 Denmark hormone replacement therapy market, by route of administration, 2021 - 2033 (USD Million)
  • Table 44 Denmark hormone replacement therapy market, by disease type, 2021 - 2033 (USD Million)
  • Table 45 Sweden hormone replacement therapy market, by product, 2021 - 2033 (USD Million)
  • Table 46 Sweden hormone replacement therapy market, by route of administration, 2021 - 2033 (USD Million)
  • Table 47 Sweden hormone replacement therapy market, by disease type, 2021 - 2033 (USD Million)
  • Table 48 Asia Pacific hormone replacement therapy market, by country, 2021 - 2033 (USD Million)
  • Table 49 Asia Pacific hormone replacement therapy market, by product, 2021 - 2033 (USD
  • Table 50 Asia Pacific hormone replacement therapy market, by route of administration, 2021 - 2033 (USD Million)
  • Table 51 Asia Pacific hormone replacement therapy market, by disease type, 2021 - 2033 (USD Million)
  • Table 52 Japan hormone replacement therapy market, by product, 2021 - 2033 (USD Million)
  • Table 53 Japan hormone replacement therapy market, by route of administration, 2021 - 2033 (USD Million)
  • Table 54 Japan hormone replacement therapy market, by disease type, 2021 - 2033 (USD Million)
  • Table 55 China hormone replacement therapy market, by product, 2021 - 2033 (USD Million)
  • Table 56 China hormone replacement therapy market, by route of administration, 2021 - 2033 (USD Million)
  • Table 57 China hormone replacement therapy market, by disease type, 2021 - 2033 (USD Million)
  • Table 58 India hormone replacement therapy market, by product, 2021 - 2033 (USD Million)
  • Table 59 India hormone replacement therapy market, by route of administration, 2021 - 2033 (USD Million)
  • Table 60 India hormone replacement therapy market, by disease type, 2021 - 2033 (USD Million)
  • Table 61 Australia hormone replacement therapy market, by product, 2021 - 2033 (USD Million)
  • Table 62 Australia hormone replacement therapy market, by route of administration, 2021 - 2033 (USD Million)
  • Table 63 Australia hormone replacement therapy market, by disease type, 2021 - 2033 (USD Million)
  • Table 64 South Korea hormone replacement therapy market, by product, 2021 - 2033 (USD Million)
  • Table 65 South Korea hormone replacement therapy market, by route of administration, 2021 - 2033 (USD Million)
  • Table 66 South Korea hormone replacement therapy market, by disease type, 2021 - 2033 (USD Million)
  • Table 67 Thailand hormone replacement therapy market, by product, 2021 - 2033 (USD Million)
  • Table 68 Thailand hormone replacement therapy market, by route of administration, 2021 - 2033 (USD Million)
  • Table 69 Thailand hormone replacement therapy market, by disease type, 2021 - 2033 (USD Million)
  • Table 70 Latin America hormone replacement therapy market, by country, 2021 - 2033 (USD Million)
  • Table 71 Latin America hormone replacement therapy market, by product, 2021 - 2033 (USD Million)
  • Table 72 Latin America hormone replacement therapy market, by route of administration, 2021 - 2033 (USD Million)
  • Table 73 Latin America hormone replacement therapy market, by disease type, 2021 - 2033 (USD Million)
  • Table 74 Brazil hormone replacement therapy market, by product, 2021 - 2033 (USD Million)
  • Table 75 Brazil hormone replacement therapy market, by route of administration, 2021 - 2033 (USD Million)
  • Table 76 Brazil hormone replacement therapy market, by disease type, 2021 - 2033 (USD Million)
  • Table 77 Argentina hormone replacement therapy market, by product, 2021 - 2033 (USD Million)
  • Table 78 Argentina hormone replacement therapy market, by route of administration, 2021 - 2033 (USD Million)
  • Table 79 Argentina hormone replacement therapy market, by disease type, 2021 - 2033 (USD Million)
  • Table 80 Middle East & Africa hormone replacement therapy market, by country, 2021 - 2033 (USD Million)
  • Table 81 Middle East & Africa hormone replacement therapy market, by product, 2021 - 2033 (USD Million)
  • Table 82 Middle East & Africa hormone replacement therapy market, by route of administration, 2021 - 2033 (USD Million)
  • Table 83 Middle East & Africa hormone replacement therapy market, by disease type, 2021 - 2033 (USD Million)
  • Table 84 South Africa hormone replacement therapy market, by product, 2021 - 2033 (USD Million)
  • Table 85 South Africa hormone replacement therapy market, by route of administration, 2021 - 2033 (USD Million)
  • Table 86 South Africa hormone replacement therapy market, by disease type, 2021 - 2033 (USD Million)
  • Table 87 Saudi Arabia hormone replacement therapy market, by product, 2021 - 2033 (USD Million)
  • Table 88 Saudi Arabia hormone replacement therapy market, by route of administration, 2021 - 2033 (USD Million)
  • Table 89 Saudi Arabia hormone replacement therapy market, by disease type, 2021 - 2033 (USD Million)
  • Table 90 UAE hormone replacement therapy market, by product, 2021 - 2033 (USD Million)
  • Table 91 UAE hormone replacement therapy market, by route of administration, 2021 - 2033 (USD Million)
  • Table 92 UAE hormone replacement therapy market, by disease type, 2021 - 2033 (USD Million)
  • Table 93 Kuwait hormone replacement therapy market, by product, 2021 - 2033 (USD Million)
  • Table 94 Kuwait hormone replacement therapy market, by route of administration, 2021 - 2033 (USD Million)
  • Table 95 Kuwait hormone replacement therapy market, by disease type, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Hormone replacement therapy market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Therapeutic approach and application outlook (USD Million)
  • Fig. 10 Competitive landscape
  • Fig. 11 Hormone replacement therapy market dynamics
  • Fig. 12 Hormone replacement therapy market: Porter's five forces analysis
  • Fig. 13 Hormone replacement therapy market: PESTLE analysis
  • Fig. 14 Product market, 2021 - 2033 (USD Million)
  • Fig. 15 Estrogen & Progesterone Replacement Therapy market, 2021 - 2033 (USD Million)
  • Fig. 16 HGH Replacement Therapy market, 2021 - 2033 (USD Million)
  • Fig. 17 Thyroid Hormone Replacement Therapy market, 2021 - 2033 (USD Million)
  • Fig. 18 Testosterone Replacement Therapy market, 2021 - 2033 (USD Million)
  • Fig. 19 Parathyroid Hormone Replacement market, 2021 - 2033 (USD Million)
  • Fig. 20 Route of administration market, 2021 - 2033 (USD Million)
  • Fig. 21 Oral market, 2021 - 2033 (USD Million)
  • Fig. 22 Parenteral market, 2021 - 2033 (USD Million)
  • Fig. 23 Transdermal market, 2021 - 2033 (USD Million)
  • Fig. 24 Others market, 2021 - 2033 (USD Million)
  • Fig. 25 Disease Type market, 2021 - 2033 (USD Million)
  • Fig. 26 Menopause market, 2021 - 2033 (USD Million)
  • Fig. 27 Hypothyroidism market, 2021 - 2033 (USD Million)
  • Fig. 28 Male Hypogonadism market, 2021 - 2033 (USD Million)
  • Fig. 29 Growth Hormone Deficiency market, 2021 - 2033 (USD Million)
  • Fig. 30 Hypoparathyroidism market, 2021 - 2033 (USD Million)
  • Fig. 31 Hormone replacement therapy market revenue, by region
  • Fig. 32 Regional marketplace: Key takeaways
  • Fig. 33 North America Hormone replacement therapy market, 2021 - 2033 (USD Million)
  • Fig. 34 U.S. country dynamics
  • Fig. 35 U.S. Hormone replacement therapy market, 2021 - 2033 (USD Million)
  • Fig. 36 Canada country dynamics
  • Fig. 37 Canada Hormone replacement therapy market, 2021 - 2033 (USD Million)
  • Fig. 38 Mexico country dynamics
  • Fig. 39 Mexico Hormone replacement therapy market, 2021 - 2033 (USD Million)
  • Fig. 40 Europe Hormone replacement therapy market, 2021 - 2033 (USD Million)
  • Fig. 41 UK country dynamics
  • Fig. 42 UK Hormone replacement therapy market, 2021 - 2033 (USD Million)
  • Fig. 43 Germany country dynamics
  • Fig. 44 Germany Hormone replacement therapy market, 2021 - 2033 (USD Million)
  • Fig. 45 France country dynamics
  • Fig. 46 France Hormone replacement therapy market, 2021 - 2033 (USD Million)
  • Fig. 47 Italy country dynamics
  • Fig. 48 Italy Hormone replacement therapy market, 2021 - 2033 (USD Million)
  • Fig. 49 Spain country dynamics
  • Fig. 50 Spain Hormone replacement therapy market, 2021 - 2033 (USD Million)
  • Fig. 51 Norway country dynamics
  • Fig. 52 Norway Hormone replacement therapy market, 2021 - 2033 (USD Million)
  • Fig. 53 Sweden country dynamics
  • Fig. 54 Sweden Hormone replacement therapy market, 2021 - 2033 (USD Million)
  • Fig. 55 Denmark country dynamics
  • Fig. 56 Denmark Hormone replacement therapy market, 2021 - 2033 (USD Million)
  • Fig. 57 Asia Pacific Hormone replacement therapy market, 2021 - 2033 (USD Million)
  • Fig. 58 Japan country dynamics
  • Fig. 59 Japan Hormone replacement therapy market, 2021 - 2033 (USD Million)
  • Fig. 60 China country dynamics
  • Fig. 61 China Hormone replacement therapy market, 2021 - 2033 (USD Million)
  • Fig. 62 India country dynamics
  • Fig. 63 India Hormone replacement therapy market, 2021 - 2033 (USD Million)
  • Fig. 64 Australia country dynamics
  • Fig. 65 Australia Hormone replacement therapy market, 2021 - 2033 (USD Million)
  • Fig. 66 South Korea country dynamics
  • Fig. 67 South Korea Hormone replacement therapy market, 2021 - 2033 (USD Million)
  • Fig. 68 Thailand country dynamics
  • Fig. 69 Thailand Hormone replacement therapy market, 2021 - 2033 (USD Million)
  • Fig. 70 Latin America Hormone replacement therapy market, 2021 - 2033 (USD Million)
  • Fig. 71 Brazil country dynamics
  • Fig. 72 Brazil Hormone replacement therapy market, 2021 - 2033 (USD Million)
  • Fig. 73 Argentina country dynamics
  • Fig. 74 Argentina Hormone replacement therapy market, 2021 - 2033 (USD Million)
  • Fig. 75 MEA Hormone replacement therapy market, 2021 - 2033 (USD Million)
  • Fig. 76 South Africa country dynamics
  • Fig. 77 South Africa Hormone replacement therapy market, 2021 - 2033 (USD Million)
  • Fig. 78 Saudi Arabia country dynamics
  • Fig. 79 Saudi Arabia Hormone replacement therapy market, 2021 - 2033 (USD Million)
  • Fig. 80 UAE country dynamics
  • Fig. 81 UAE Hormone replacement therapy market, 2021 - 2033 (USD Million)
  • Fig. 82 Kuwait country dynamics
  • Fig. 83 Kuwait Hormone replacement therapy market, 2021 - 2033 (USD Million)
  • Fig. 84 Company categorization
  • Fig. 85 Company market position analysis
  • Fig. 86 Strategic framework